Titan Pharmaceuticals, Inc. (Nasdaq: TTNP), relating to its proposed merger with BSKE Ltd. Under the terms of the agreement, Titan shareholders are expected to own approximately 13.3% of the combined company.
Titan Pharmaceuticals, Inc. (Nasdaq: TTNP), relating to its proposed merger with BSKE Ltd. Under the terms of the agreement, Titan shareholders are expected to own approximately 13.3% of the combined company.